FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1149152001: Trilaciclib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4554214018 Trilaciclib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4554215017 Trilaciclib en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trilaciclib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Trilaciclib Is a Substance with protein kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Trilaciclib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Trilaciclib Has disposition Protein kinase inhibitor true Inferred relationship Existential restriction modifier
Trilaciclib Is a Pyrrole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trilaciclib dihydrochloride Is modification of True Trilaciclib Inferred relationship Existential restriction modifier
Product containing only trilaciclib (medicinal product) Has active ingredient True Trilaciclib Inferred relationship Existential restriction modifier 1
Product containing trilaciclib in parenteral dose form (medicinal product form) Has active ingredient True Trilaciclib Inferred relationship Existential restriction modifier 1
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance False Trilaciclib Inferred relationship Existential restriction modifier 1
Product containing trilaciclib (medicinal product) Has active ingredient True Trilaciclib Inferred relationship Existential restriction modifier 1
Product containing only trilaciclib in parenteral dose form (medicinal product form) Has active ingredient True Trilaciclib Inferred relationship Existential restriction modifier 1
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Trilaciclib Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start